Description
CJC-1295 (Without DAC) 5mg – Research Peptide
CJC-1295 (Without DAC) 5mg is a high-purity, research-grade synthetic peptide supplied for controlled laboratory investigation involving growth hormone–related signaling pathways, peptide-receptor interactions, and endocrine system research.
CJC-1295 without DAC is a modified analog of growth hormone–releasing hormone (GHRH 1–29). Peptides of this class are referenced in scientific literature examining molecular pathways associated with pituitary signaling and growth hormone regulatory systems.
The non-DAC formulation represents a short-duration variant of CJC-1295 commonly referenced in laboratory models examining peptide activity over shorter observation windows.
CJC-1295 (Without DAC) 5mg is supplied strictly for in-vitro laboratory research and analytical investigation. This compound is not approved for human or veterinary use.
What Is CJC-1295 (Without DAC)?
CJC-1295 (No DAC) is a synthetic peptide structurally related to fragments of endogenous growth hormone–releasing hormone (GHRH).
In scientific literature, GHRH analogues have been examined in experimental models involving endocrine signaling pathways and pituitary receptor interactions.
Research discussions referencing CJC-1295 and related peptides have examined topics including:
• Growth hormone–associated signaling pathways
• Pituitary receptor interaction models
• IGF-1 related molecular signaling systems
• Endocrine communication pathways
• Circadian hormone signaling research
These areas remain subjects of ongoing experimental investigation.
Areas of Scientific Investigation
Research literature referencing CJC-1295 and related GHRH analogues has examined laboratory models involving:
• Growth hormone signaling pathway analysis
• Pituitary receptor binding studies
• IGF-1 related molecular pathway research
• Endocrine system signaling investigations
• Circadian rhythm models involving hormone signaling
These references are provided for informational context regarding the compound’s presence in scientific research.
Laboratory Research Contexts
Researchers may investigate CJC-1295 (Without DAC) within experimental frameworks such as:
• Peptide-receptor interaction studies
• Endocrine signaling pathway analysis
• Pituitary signaling research models
• Molecular pathway investigations involving GHRH analogues
• Peptide structure and stability studies
CJC-1295 (Without DAC) 5mg – Research Supply Specifications
• Synthetic research peptide
• 5mg lyophilized peptide per vial
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality verification
Purity & Quality Assurance
ExoLabz supplies research peptides manufactured to high analytical standards. ExoLabz products undergo independent third-party testing to verify peptide identity and purity. Results are published on this site.
Researchers may perform additional analytical verification if required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.
Important Legal Notice
For Research Purposes Only
CJC-1295 (Without DAC) 5mg is supplied strictly for laboratory research and analytical use.
This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.
This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.
By purchasing this product, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.
Compound identity and specification
Identity data for CJC-1295 without DAC (Mod GRF 1-29), published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.
| Compound | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|
| Sequence | [D-Ala2, Gln8, Ala15, Leu27]-GRF(1-29) amide |
| Molecular formula | C152H252N44O42 |
| Molecular mass | 3367.9 g/mol |
| CAS registry number | 863288-34-0 |
| PubChem | CID 56841945 |
| Vial content | 5 mg |
| Physical form | Lyophilised powder in a sealed vial |
| Analysis | Third-party HPLC; the result for this product is published on this page |
| Supplied for | Laboratory research use only |
Analytical note — CJC-1295 without DAC (Mod GRF 1-29). This is the version without the drug-affinity complex. CJC-1295 with DAC is a different molecule, C165H269N47O46 at about 3,647 g/mol, CAS 446262-90-4 – a difference of roughly 280 Da. The two are the most commonly confused pair in this category, and the mass on the certificate is what separates them.
Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Jette L, et al. Endocrinology. 2005;146(7):3052-3058. In cultured rat anterior pituitary cells and Sprague-Dawley rats, measured GH secretion, Cys34-albumin conjugate formation and resistance to DPP-IV cleavage. Source · PMID 15817669
- Alba M, et al. Am J Physiol Endocrinol Metab. 2006;291(6):E1290-E1294. In GHRH-knockout mice, measured pituitary GH and IGF-I expression. Source · PMID 16822960
Related Research Compounds
Browse more compounds in GHS, or view the full research peptide catalogue.
